Plasma IL-6 levels increase during IR associated with obesity and diabetes; therefore, IL-6 plasma concentration may represent an independent predictor of risk for T2DM (22). This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.